抑制心肌纤维化促进心肌再生治疗慢性心血管疾病被引量：8

Suppressing Myocardial Fibrosis to Promote Myocardial Regeneration as a Therapeutic Strategy for Chronic Cardiovascular Diseases

下载PDF

导出

摘要以心肌肥厚、心肌细胞丢失和心肌组织纤维化为特征的心脏组织异常重构是各种慢性心血管疾病的核心病理改变。以组织异常重构,特别是以组织纤维化为靶点,利用小分子化合物如松弛素、KNK437,生物制剂如BCG、抗TLR2抗体或中药复方CFX等改变炎症性质,抑制甚至逆转纤维化不仅可以有效地改善心脏功能,还可为干细胞的动员和生长提供适宜环境,促进心肌再生,是治疗慢性心血管疾病的重要途径。 Abnormal cardiovascular tissue remodeling characterized by myocardial hypertrophy,myocardial cell loss and myocardial fibrosis,are the primary pathological changes for multiple cardiovascular diseases.Targeting tissue remodeling using small molecules（e.g.relaxin,KNK437）,biological agents（e.g.BCG,anti-TLR2 antibody）,or herb medicine complex CFX and so on,can attenuate tissue fibrosis and improve cardiac functions.Therefore,regulating the property of inflammation and reversing tissue fibrosis should promote the formation of optimal tissue environments for stem cells mobilization and proliferation,which enhances the myocardial regeneration and is potential therapeutic strategy against chronic cardiovascular diseases.

作者米粟胡卓伟

机构地区中国医学科学院北京协和医学院药物研究所

出处《生理科学进展》 CAS CSCD 北大核心 2010年第5期352-358,共7页 Progress in Physiological Sciences

基金教育部长江学者特聘教授基金科技部"973"计划项目(2006CB503808) 国家自然科学基金(30973557)资助

关键词慢性心血管疾病心肌纤维化心肌再生炎症干细胞治疗 chronic cardiovascular diseases myocardial fibrosis myocardial regeneration inflammation stem cell therapy

分类号 R542.23 [医药卫生—心血管疾病] R967 [医药卫生—药理学]

引文网络
相关文献

参考文献20

1Heineke J,Molkentin JD.Regulation of cardiac hypertrophy by intracellular signalling pathways.Nat Rev Mol Cell Biol,2006,7:589-600.
2Liu YY,Cai WF,Yang HZ,et al.Bacillus Calmette-Guerin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment.J Immunol,2008,180:7349-7357.
3Burstein B,Nattel S.Atrial fibrosis:mechanisms and clinical relevance in atrial fibrillation.J Am Coll Cardiol,2008,51:802-809.
4胡卓伟.组织纤维化疾病的免疫生物学机制.牛建昭,贲长恩.器官纤维化基础及中医药防治.北京:人民卫生出版社,2008.171-195.
5Yacoub S,Kotit S,Mocumbi AO,et al.Neglected diseases in cardiology:a call for urgent action.Nat Clin Pract Cardiovasc Med,2008,5:176-177.
6Yellon DM,Hausenloy DJ.Myocardial reperfusion injury.N Engl J Med,2007,357:1121-1135.
7Kobayashi K,Luo M,Zhang Y,et al.Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction.Nat Cell Biol,2009,11:46-55.
8Mirotsou M,Zhang Z,Deb A,et al.Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.Proc Natl Acad Sci USA,2007,104:1643-1648.
9Olivotto I,Cecchi F,Poggesi C,et al.Developmental origins of hypertrophic cardiomyopathy phenotypes:a unifying hypothesis.Nat Rev Cardiol,2009,6:317-321.
10King A.Cardiomyopathies:New insights into hypertrophic cardiomyopathy.Nat Rev Cardiol,2009,6:611.